Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2026-01-14 @ 3:03 PM
Study NCT ID:
NCT03274661
Status:
COMPLETED
Last Update Posted:
2023-10-19
First Post:
2017-09-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors
Sponsor:
Baptist Health South Florida
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MK-3475-663
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None